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ABSTRACT Background: Reoperative surgery involving the atrioventricular valves places the pa- 
tient a t  risk for cardiac or bypass graft injury upon reoperative sternotomy. Standard right tho- 
racotomy can avoid these problems but is associated with a large incision and possibly more pul- 
monary complications. Methods and Results: An alternative, minimally invasive approach for 
reoperative atrioventricular valve surgery was studied in 22 patients. Patient age was 66 f 10 
years. Postoperative mitral regurgitation was 3.4 0.3 and New York Heart Association (NYHA) 
Class was III/IV, despite a mean ejection fraction of 44 & 14%. These patients had 1-4 prior pro- 
cedures a mean of 5 years previously. An anterior 5th interspace incision of 5- t o  10-cm was per- 
formed. A l -cm segment of 5th rib was removed to  facilitate exposure. Cardiopulmonary bypass 
was performed via ascending aorta or femoral artery cannula and bicaval venous cannulae. Sys- 
temic cooling (25") and fibrillatory arrest was used. Operations performed included mitral valve 
repair (12). mitral valve replacement (51, prosthetic mitral valve rereplacement (4). repair of 
perivalvular leak (31, tricuspid valve repair (51, and atrial septa1 defect closures (7). Mean bypass 
time was 109 f 21 minutes with a mean fibrillatory time of 62 12 minutes. There was no in- 
traoperative or 30-day mortality. Patients were weaned from ventilation at a mean of 5 hours 
postoperatively and received 1.3 -c 1 unit of blood. There were no wound complications or re- 
explorations for bleeding. At a mean follow-up of 15 f 8 months, survivors are NYHA Class 1-11. 
When interviewed, al l  patients felt their recovery was more rapid and less painful than their orig- 
inal sternotorny. Conclusion: This minimally invasive approach to reoperative atrioventricular 
valve surgery is safe and technically feasible. It has become our preferred approach to  the atri- 
oventricular valves in patients with a previous sternotomy. fJ Card Surg 7998; 73;468-4701 
The potential dangers associated with reopera- 
tive sternotomy are well known to most cardiac 
surgeons. These reoperative candidates have 
aged and many have accumulated additional co- 
morbid medical conditions since their previous 
cardiac operation. Moreover, valvular heart dis- 
ease is accompanied by atrial dilation and car- 
diomegaly, which brings the thinned atrial wall in 
close apposition to the posterior sternum where 
it is poised for inadvertent injury during rester- 
notomy. Additional risks include injury to patent 
bypass grafts, embolism of atherosclerotic debris 
dislodged from diseased aorta to patent bypass 
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grafts, as well as great vessel and phrenic nerve 
injury. These risks are often underestimated, but 
have been reported to be approximately 4Y0.1.2 
Since 1990, we have successfully approached 
the atrioventricular valves in reoperative patients 
via a right thoracotomy. More recently, we have 
been able to significantly minimize the size of the 
incision by altering our surgical technique. This ar- 
ticle describes our current technique and early ex- 
perience with minimally invasive reoperative atri- 
oventricular valve surgery at the University of 
Michigan Medical Center. 
METHODS 
Twenty-two patients underwent a minimally in- 
vasive right thoracotomy approach to the atri- 
oventricular valves between December 1996 and 
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October 1997 at the University of Michigan Med- 
ical Center. Patient demographic, operative, and 
postoperative data were collected prospectively. 
Operation 
Informed consent was obtained during the pre- 
operative clinic visit and patients were admitted 
the morning of operation. After anesthetic induc- 
tion, intubation was accomplished with a double- 
lumen endotracheal tube, and the patient was po- 
sitioned for right anterolateral thoracotomy. 
External defibrillation pads were placed anterior 
and posterior on the chest wall out of the opera- 
tive field. Skin preparation and draping proceeded 
in the usual sterile manner. A 5 to 1 O-cm incision 
was made over the 5th rib in the inframammary 
fold. The breast was elevated from the chest wall 
and the serratus anterior muscle elevated along 
its lateral border and partially divided inferiorly. 
The fatissirnus dorsi muscle was retracted poste- 
riorly. A l-cm segment of the 5th rib was removed 
and the right lung collapsed to facilitate exposure. 
The pericardium was opened 1 cm anterior to the 
phrenic nerve from the superior vena cava to the 
inferior vena cava over the interatrial groove. The 
lung was covered with a moist lap, and stay su- 
tures were placed along the posterior pericardial 
edge and brought out through the chest wall pos- 
terior to the incision under light traction. Arterial 
cannulation was accomplished in the ascending 
aorta (1 5 patients) or in the right femoral artery (7 
patients). If necessary, a Icm segment of 4th rib 
was removed anteriorly, which greatly enhanced 
exposure of the aorta and simplified aortic cannu- 
lation. Bicaval venous cannulation was performed 
through the main incision using open-ended right- 
angled cannulae. On occasion, the inferior caval 
cannula was placed through a separate stab inci- 
sion that was later used for a chest thoracostomy 
tube. After bypass was initiated, a left ventricular 
vent was placed through the right superior pul- 
monary vein and cooling commenced to 25°C. The 
left atrium was opened after spontaneous fibrilla- 
tion. The operation was performed on the per- 
fused heart without damping the aorta. Air was 
evacuated from the heart by allowing the left ven- 
tricle and left atrium to fill with blood dependently 
during left atrial closure. Residual air was removed 
with the aid of a left atrial and ascending aortic 
vent. Patients were rewarmed, weaned from by- 
pass, and decannulated in the usual manner. In 
those patients who required atrial septal defect 
closure or tricuspid valve procedures in addition to 
a mitral valve procedure, the approach to the mi- 
tral valve was through the right atrium and the in- 
teratrial septum. Marcaine rib blocks were placed 
at chest closure to facilitate early postoperative 




Patient age was 66 t 10 years. Preoperative 
mitral regurgitation was 3.4 ? 0.3 on a scale of 1 to 
4 by transesophageal echocardiography. NYHA 
Class was III/IV in all patients despite a preopera- 
tive ejection fraction of 44 2 14%. Previous cardiac 
operations included coronary artery bypass graft- 
ing and aortic and mitral valve surgery. The number 
of previous cardiac operations ranged from 1 to 4 
with a mean of 5 years since the last operation. 
Operation 
Operations performed included 12 mitral valve 
repairs, 5 mitral valve replacements, 4 mitral 
valve rereplacements, 3 repairs of periprosthetic 
leaks, 5 tricuspid valve repairs, and 7 atrial septal 
defecvpatent foramen ovale closures. Mean car- 
diopulmonary bypass times were 109 -+ 21 min- 
utes with a mean fibrillatory time of 62 ? 12 min- 
utes.There was no intraoperative mortality. 
Postoperation 
Patients were weaned from ventilatory support 
at  a mean of 5 hours postoperatively and required 
an average of 1.3 -+ 1.0 units of blood. There 
were no wound complications or re-explorations 
for bleeding. No neurological or embolic compli- 
cations were encountered. Thirty-day mortality 
was 0% with one late death from multiorgan fail- 
ure. Although there was not a randomized, con- 
temporaneous, "control" group, mean postoper- 
ative ICU, and total LOS were 1 day and 5.9 days, 
respectively. There was no incidence of postop 
low output syndrome or IABP use. 
Follow-UP 
The duration of follow- up was 15 2 8 months. 
Of the survivors, all were in NYHA Class I or I I .  
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When interviewed, all patients felt their recovery 
was more rapid and less painful than their previ- 
ous sternotomy. There were no wound healing 
complications or infections. 
CONCLUSIONS 
Although right thoracotomy was one of the ini- 
tial methods described for mitral valve surgery, 
most surgeons trained in the last 10 to 15 years 
have a limited experience with this approach and 
prefer median sternotomy for most atrioventricu- 
lar valve operations. The patient with a previous 
sternotomy who requires atrioventricular valve 
surgery deserves special consideration because 
resternotomy is associated with additional risks 
not present in their initial operation. As such, sev- 
eral authors have demonstrated the utility of right 
thoracotomy for reoperative atrioventricular valve 
surgery in patients with a previous stern~tomy.~-* 
Most surgeons will agree that unintentional 
cardiac or bypass graft injury is reduced with the 
thoracotomy approach. In fact, decreased cardio- 
pulmonary bypass times, blood loss, and blood 
product usage have been demonstrated in reop- 
erative patients undergoing right thoracotomy as 
opposed to re~ternotomy.3,~ 
Since 1990, w e  have been using the right tho- 
racotomy approach to the isolated redo atrio- 
ventricular valves in patients with previous ster- 
notomy.* With the advent of minimally invasive 
techniques and a mind-set toward minimizing the 
surgical incision, alterations in our technique now 
enable us to safely perform reoperative atrioven- 
tricular valve surgery through a 5- to 10-cm inci- 
sion. All the excellent results and advantages of 
right thoracotomy over resternotomy previously 
presented* are preserved, and the additional ben- 
efits of a smaller, more cosmetic incision and less 
postoperative discomfort are conferred. 
Proper patient selection is paramount to suc- 
cess and safety. Patients who require aortic valve 
procedures and/or coronary artery bypass graft- 
ing in addition to atrioventricular valve surgery are 
better served with resternotomy. We have how- 
ever, in two cases grafted the right coronary 
artery through a right thoracotomy, as well as per- 
formed redo mitral valve surgery, without diffi- 
culty. These patients did well. However, any aor- 
tic insufficiency can make exposure to the mitral 
valve difficult. A high profile Starr-Edwards aortic 
prosthesis usually has no aortic insufficiency with 
hypothermic fibrillation. However, the position 
of the cage apparatus must be kept in mind 
when cannulating the right lateral ascending aorta 
through the right chest approach. Although we 
have successfully used this mini-approach in pa- 
tients with a previous right thoracotomy, signifi- 
cant scarring or right pleural disease may present 
a technical challenge. Proper patient selection and 
forethought can prevent intraoperative problems 
and surprises. If additional exposure is needed 
during the course of the operation, the incision is 
easily extended posterior or anterior across the 
sternum, although we have never found an ante- 
rior extension necessary. 
In conclusion, our experience with an alterna- 
tive, minimally invasive right anterolateral ap- 
proach for reoperative atrioventricular valve sur- 
gery has been quite favorable. Patient satisfaction 
and comfort as well as surgeon satisfaction with 
safety and exposure are quite high. We continue 
to employ this approach a t  our institution and en- 
courage other surgeons to consider its benefits. 
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